Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 2.1 Stock Exchange Agreement by and Among the Registrant, Lipovation and Lipovation's Shareholders Dated November 14, 2023
- 3.3 Certificate of Amendment to the Certificate of Incorporation of the Registrant Dated October 14, 2008 Changing the Name of the Registrant from to Grand Canal Entertainment, Inc. to Oc Beverages, Inc.
- 3.4 Certificate of Amendment to the Certificate of Incorporation of the Registrant Dated December 9, 2020 Changing the Name of the Registrant from Oc Beverages, Inc. to Revium Recovery, Inc.
- 3.5 Articles of Incorporation of the Registrant In the State of Nevada
- 3.6 Plan of Conversion of the Registrant, Dated December 17, 2024
- 3.7 Certificate of Conversion Filed with the State of Delaware
- 3.9 Bylaws of the Registrant In the State of Nevada
- 4.1 Form of the Ipo Warrants to Be Issued by the Company In This Offering
- 4.2 Form of Investor Warrants Issued by the Company In the First Private Placement Offering
- 4.3 Form of Investor Warrants Issued by the Company In the Second Private Placement Offering
- 10.1 License and Research Agreement Between Yissum Research Development Company of the Hebrew University of Jerusalem, LTD. and Lipovation, Effective As of November 24, 2022 (Muprocin)
- 10.2 First Amendment to the License and Research Agreement Yissum Research Development Company of the Hebrew University of Jerusalem, LTD. and Lipovation, Effective October 25, 2023 (Muprocin)
- 10.3 Second Amendment to the License and Research Agreement Yissum Research Development Company of the Hebrew University of Jerusalem, LTD. and Lipovation, Effective October 25, 2023 (Muprocin)
- 10.4 License and Research Agreement Between Yissum Research Development Company of the Hebrew University of Jerusalem, LTD. and Lipovation, Effective As of November 24, 2022 (Ov)
- 10.5 First Amendment to the License and Research Agreement Yissum Research Development Company of the Hebrew University of Jerusalem, LTD. and Lipovation, Effective October 25, 2023 (Ov)
- 10.6 Research and Option Agreement Effective As of October 25, 2023 (Arb)
- 10.7 Research and Option Agreement Between Yissum Research Development Company of the Hebrew University of Jerusalem, LTD. and Lipovation, Effective As of March 16, 2021
- 10.8 First Amendment to the Research and Option Agreement Between Yissum Research Development Company of the Hebrew University of Jerusalem, LTD. and Lipovation, Effective As of June 8, 2021
- 10.9 Second Amendment to the Research and Option Agreement Between Yissum Research Development Company of the Hebrew University of Jerusalem, LTD. and Lipovation, Effective As of August 1, 2021
- 10.10 Form of Subscription Agreement Executed by the Registrant and Subscribers In the First Private Placement Offering
- 10.11 Form of Subscription Agreement Executed by the Registrant and Subscribers In the Second Private Placement Offering
- 10.13 Employment Agreement Dated As of February 1, 2024 Between Inna Martin and Revium LTD
- 10.14 Consulting Agreement Dated As of Dec 15, 2020 Between Inna Martin and Revium LTD
- 10.15 Amendment to Consulting Agreement June 29, 2023 Between Inna Martin and Revium LTD
- 10.16 Amendment to Consulting Agreement Dated December 24, 2024 Between Inna Martin and Revium LTD
- 10.17 Employment Agreement Dated As of December 18, 2024 Between David Akunis and Revium LTD
- 23.1 Consent of Independent Registered Public Accounting Firm
- 23.2 Consent of Independent Registered Public Accounting Firm
- EX-FILING FEES Filing Fee Table
Filing view
External links